Peer-reviewedCC BYAntioxidants (Basel, Switzerland)
Xiaochaihutang Extract Ameliorates Metabolic Dysfunction-Associated Steatohepatitis in Mice and Modulates the Gut–Liver Axis
Related
- Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
- Commentary: Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis
- Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis (MASLD/MASH) and Cardiovascular Risk: Emerging Therapeutic Strategies at the Interface of Liver and Cardiometabolic Disease
- GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and meta-analysis of randomized controlled trials
- Hepatic Lipid Stress Drives Metabolic Dysfunction‐Associated Steatohepatitis Progression through FTO O‐GlcNAcylation‐Induced m6A Demethylation of HRAS
BibTeX
@article{anon2026xiaochaihutang,
title = {{Xiaochaihutang Extract Ameliorates Metabolic Dysfunction-Associated Steatohepatitis in Mice and Modulates the Gut–Liver Axis}},
journal = {Antioxidants (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13700607},
note = {CC BY},
}
RIS
TY - JOUR
TI - Xiaochaihutang Extract Ameliorates Metabolic Dysfunction-Associated Steatohepatitis in Mice and Modulates the Gut–Liver Axis
PY - 2026
DA - 2026/10/01
JO - Antioxidants (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13700607
SN - 2076-3921
ER -